The relation ship between concentration of circulating soluble E- selectin and clinical, pathological, and biological features in patients with breat cancer

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 373-380

  Hebbar, Mohamed ^a   Révillion, Françoise ^a   Louchez, Marie Michèle ^a   Vilain, Marie Odile ^a   Fournier, Charles ^a   Bonneterre, Jacques ^a   Peyrat, Jean Philippe ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HORMONE; METHOTREXATE; MITOMYCIN; NAVELBINE; C REACTIVE PROTEIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EXAMINATION; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY BREAST CANCER; LIVER METASTASIS; MAJOR CLINICAL STUDY; MASTITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION; BLOOD; BREAST TUMOR; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; METABOLISM; METASTASIS; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SOLUBILITY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD SEDIMENTATION; BREAST NEOPLASMS; C-REACTIVE PROTEIN; E-SELECTIN; FEMALE; HUMANS; INTERLEUKIN-1; MIDDLE AGED; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031594260     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76: 301-314, 1994.
2. Carlos, T. M., and Harlan, J. M. Leukocyte-endothelial adhesion molecules. Blood, 84: 2068-2101, 1994.
3. Bevilacqua, M. P., Pober, J. S., Mendrick, D. L., Cotran, R. S., and Gimbrone, M. A., Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA, 84: 9238-9242, 1987.
4. Pigott, R., Dillon, L. P., Hemingway, I. H., and Gearing, A. J. H. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine-activated cultured endothelial cells. Biochem. Biophys. Res. Commun., 2: 584-589, 1992.
5. Leeuwenberg, J. F. M., Jeunhomme, T. M. A. A., and Buurman, W. A. Role of ELAM-1 in adhesion of monocytes to activated human endothelial cells. Scand. J. Immunol., 35: 335-341, 1992.
6. McCarthy, J. B., Skubitz, A. P. N., Ilda, J., Mooridian, D. L., Wilke, M. S., and Furcht, L. T. Tumor cell adhesive mechanisms and their relationship to metastasis. Semin. Cancer Biol., 2: 155-167, 1991.
7. Zetter, B. R. Adhesion molecules in tumor metastasis. Semin. Cancer Biol., 4: 219-229, 1993.
8. Nguyen, M., Strubel, N. A., and Bishoff, J. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature (Lond.), 365: 267-269, 1993.
9. Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., and Polverini, P. J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (Lond.), 376: 517-519, 1995.
10. X antigens. Semin. Cancer Biol., 4: 319-324, 1993.
11. X antigen. Exp. Cell Res., 196: 20-25, 1991.
12. X as a new tumor-associated antigen. Cancer Res., 44: 5279-5285, 1984.
13. Tozeren, A., Kleinman, H. K., Grant, D. S., Morales, D., Mercurio, A. M., and Byers, S. W. E-selectin-mediated dynamic interactions of breast and colon cancer cells with endothelial cell monolayers. Int. J. Cancer, 60: 426-431, 1995.
14. WHO. Handbook for Reporting Results of Cancer Treatment. WHO Offset Publ. No. 48, Geneva: WHO, 1979.
15. Hsu, S. M., and Raine, L. The use of avidin-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In: R. A. DeLellis (ed.), Advances in Immunohistochemistry, pp. 31-42. New York: Masson, 1984.
16. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
17. Steinbach, F., Tanabe, K., Alexander, J., Edinger, M., Tubbs, R., Brenner, W., Stockle, M., Novick, A. C., and Klein, E. A. The influence of cytokines on the adhesion of renal cancer cells to endothelium. J. Urol., 155: 743-748, 1996.
18. Miller, N., Vile, R. G., and Hart, I. R. Selectin ligands on human melanoma cells. Glycoconj. J., 13: 33-43, 1996.
19. Biancone, L., Araki, M., Araki, K., Vassalli, P., and Stamenkovic, I. Redirection of tumor metastasis by expression of E-selectin in vivo. J. Exp. Med., 183: 581-587, 1996.
20. Ye, C. L., Ito, K., Kannagi, R., Kiriyama, K., Kondo, K., Akiyama, S., and Takagi, H. The significance of E-selectin in hematogenous metastasis of human colorectal cancer. Proc. Am. Assoc. Cancer Res., 36: 82, 1995.
21. Fox, S. B., Turner, G. D. H., Gatter, K. C., and Harris, A. L. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium. J. Pathol., 177: 369-376, 1995.
22. Banks, R. E., Gearing, A. J., Hemingway, I. K., Norfolk, D. R., Perren, T. J., and Selby, P. J. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br. J. Cancer, 68: 122-124, 1993.
23. Matsuura, N., Narita, T., Mitsuoka, C., Kimura, N., Kannagi, R., Imai, T., Funahashi, H., and Takagi, H. Increased concentrations of soluble E-selectin in the sera of breast cancer patients. Anticancer Res., 17: 1367-1372, 1997.
24. Wittig, B. M., Kaulen, H., Thees, R., Schmitt, C., Knolle, P., Stock, J., Meyer zum Büschenfelde, K. H., and Dippold, W. Elevated serum E-selectin in patients with liver metastases of colorectal cancer. Eur. J. Cancer, 32A: 1215-1218, 1996.
25. Muraki, J., Kobayashi, M., Sugaya, Y., Hashimoto, S. I., Morita, T., Kobayashi, Y., and Tokue, A. Role of serum E-selectin (ELAM-1) and inflammatory parameters in patients with renal cell carcinoma. Jpn. J. Urol., 87: 831-841, 1996.
26. Mitsuoka, C., and Kannagi, R. Clinical significance of circulating soluble E-selectin (ELAM-1) in patients with cancers. Nippon Rinsho, 53: 1770-1775, 1995.